![]() |
市場調查報告書
商品編碼
1955065
全球便攜式超音波市場:市場規模、佔有率、成長率、行業分析、依類型、應用和地區劃分的分析以及未來預測(2026-2034 年)Portable Ultrasound Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025 年全球便攜式超音波市場規模為 33.7 億美元,預計 2026 年將成長至 37.7 億美元。預計到 2034 年,該市場規模將達到 90.7 億美元,在預測期(2026-2034 年)內複合年增長率 (CAGR) 為 11.58%。
北美地區引領全球市場,在 2025 年佔 36.04% 的市場佔有率,這得益於其強大的醫療保健基礎設施和先進診斷成像技術的快速普及。
便攜式超音波系統是一種緊湊型行動影像設備,用於在多個專科領域進行即時診斷評估,包括:心臟病學、產科、骨科和急診醫學。門診和床邊應用的增加顯著推動了市場成長。
新冠疫情的影響
由於擇期手術取消和就診量下降,新冠疫情對便攜式超音波市場造成了負面影響。由於封鎖措施和醫療資源集中用於應對疫情,常規診斷影像受到限制。供應鏈中斷和生產放緩也影響了銷售。
然而,由於超音波設備偶爾用於診斷伴有肺部和心臟併發症的新冠患者,需求出現了有限的增長。疫情後的復甦恢復了成長勢頭,預計到2034年將保持強勁的複合年增長率。
市場驅動因素
急診醫學領域應用增加
便攜式超音波系統在急診室的廣泛應用是市場驅動因素之一。這些設備可提供快速、即時的成像,並支援即時的臨床決策。其非侵入性和快速部署的特性使其成為創傷護理和急救醫療環境中不可或缺的工具。
產品發布增加
持續的技術創新和新產品的推出正在推動進一步成長。各公司正在整合先進的成像功能、無線功能和人工智慧驅動的診斷工具。例如,手持式和無線系統的推出正在將其應用範圍從傳統的醫院擴展到門診和遠距醫療環境。
市場限制因子
有限的報銷政策和監管問題仍然是主要挑戰。在某些地區,超音波檢查只有在符合嚴格標準的情況下才能獲得報銷。此外,監管機構對潛在的不必要影像和誤診的審查可能會阻礙其普及。這些因素可能會在預測期內抑製成長。
最新趨勢
人工智慧 (AI) 的整合
人工智慧 (AI) 的整合是重要的市場趨勢。 AI 驅動的超音波系統能夠提高影像解讀的準確性、實現自動測量並增強診斷準確性。基於深度學習的量化工具在診斷影像軟體中的整合正在不斷增加。
此外,手持式超音波設備的廣泛應用正在擴大初級保健、家庭醫療保健和遠距醫療中診斷影像的覆蓋範圍,從而支持市場的長期成長。
依類型
市場依類型分為內建控制台型和觸控螢幕型。
依最終使用者劃分
依最終用戶劃分,市場分為醫院和診所。
北美
北美市場規模位居榜首,2025年市場規模達12.1億美元,2026年達13.4億美元。光是美國市場預計在2026年就將達到13.1億美元,主要得益於高癌症發生率和對急診影像診斷的強勁需求。
歐洲
歐洲市場規模位居第二,這主要得益於醫療保健支出的成長和新產品的推出。預計2026年,英國市場規模將達1.9億美元,德國市場規模將達2.7億美元。 亞太地區 預計到2034年,亞太地區的複合年增長率將最高。到2026年,在醫療保健投資不斷增長和龐大患者群體的推動下,預計日本市場規模將達到5.7億美元,中國將達到4.5億美元,印度將達到9,000萬美元。
拉丁美洲、中東和非洲
截至2025年,這些地區的市場佔有率相對較小,但由於基礎設施的改善以及人們對便攜式醫療影像益處的認識不斷提高,預計未來將實現強勁增長。
The global portable ultrasound market was valued at USD 3.37 billion in 2025 and is projected to grow to USD 3.77 billion in 2026. The market is forecasted to reach USD 9.07 billion by 2034, exhibiting a CAGR of 11.58% during the forecast period (2026-2034).
North America dominated the global market with a 36.04% market share in 2025, driven by strong healthcare infrastructure and rapid adoption of advanced diagnostic imaging technologies.
Portable ultrasound systems are compact, mobile imaging devices used for real-time diagnostic assessment across multiple specialties, including cardiology, obstetrics, orthopedics, and emergency medicine. Their increasing use in outpatient settings and point-of-care applications is significantly boosting market growth.
COVID-19 Impact
The COVID-19 pandemic had a negative impact on the portable ultrasound market due to the cancellation of elective procedures and reduced hospital visits. Lockdowns and healthcare resource diversion toward pandemic management limited routine diagnostic imaging. Supply chain disruptions and manufacturing slowdowns also affected sales.
However, ultrasound devices were occasionally used in COVID-19 diagnosis for lung and cardiac complications, creating limited positive demand. Post-pandemic recovery has restored growth momentum, contributing to the strong CAGR projected through 2034.
Market Drivers
Rising Adoption in Emergency Care
One of the major drivers of market growth is the extensive use of portable ultrasound systems in emergency departments. These devices provide rapid, real-time imaging and support immediate clinical decisions. Their non-invasive nature and quick deployment make them essential tools in trauma care and critical settings.
Increasing Product Launches
Continuous innovation and new product introductions are further fueling growth. Companies are integrating advanced imaging capabilities, wireless functionality, and AI-powered diagnostic tools. For example, the introduction of handheld and wireless systems has expanded usage beyond traditional hospital environments into ambulatory and remote care settings.
Market Restraints
Limited reimbursement policies and regulatory concerns remain key challenges. In some regions, ultrasound procedures qualify for reimbursement only under strict criteria. Additionally, regulatory scrutiny over unnecessary imaging and potential misdiagnosis may limit broader adoption. These factors could restrain growth during the forecast period.
Latest Trends
Integration of Artificial Intelligence
The incorporation of artificial intelligence (AI) is a prominent market trend. AI-enabled ultrasound systems enhance image interpretation, automate measurements, and improve diagnostic accuracy. Deep learning-based quantification tools are increasingly being integrated into imaging software.
Furthermore, the rising popularity of handheld ultrasound devices is expanding access to imaging across primary care, home healthcare, and telemedicine, thereby supporting long-term market expansion.
By Type
The market is segmented into built-in console and touchscreen systems.
By End User
Based on end users, the market is segmented into hospitals and clinics.
North America
North America led the market with a valuation of USD 1.21 billion in 2025 and USD 1.34 billion in 2026. The U.S. market alone is projected to reach USD 1.31 billion in 2026, supported by high cancer incidence rates and strong demand for emergency imaging.
Europe
Europe is the second-largest market, driven by strong healthcare spending and new product launches. The U.K. market is projected to reach USD 0.19 billion in 2026, while Germany is expected to reach USD 0.27 billion in 2026.
Asia Pacific
Asia Pacific is anticipated to record the highest CAGR through 2034. By 2026, Japan is projected to reach USD 0.57 billion, China USD 0.45 billion, and India USD 0.09 billion, supported by growing healthcare investments and a large patient base.
Latin America & Middle East & Africa
These regions held comparatively smaller shares in 2025 but are expected to witness strong growth due to infrastructure improvements and rising awareness of portable imaging benefits.
Competitive Landscape
The market features strong competition among global and regional players. Leading companies include GE Healthcare and Koninklijke Philips N.V., which hold significant shares due to robust product portfolios and continuous R&D investments. Other prominent players include Fujifilm Sonosite, Mindray, CHISON, Hitachi Ltd., Butterfly Network, and EDAN Instruments.
Recent developments include the launch of GE Healthcare's Vscan Air wireless ultrasound system and Philips' FDA-approved ultrasound portfolio for COVID-19-related complications management.
Conclusion
The global portable ultrasound market is poised for substantial growth from USD 3.37 billion in 2025 to USD 9.07 billion by 2034, driven by technological advancements, increasing outpatient care, and rising demand for point-of-care diagnostics. While reimbursement challenges and regulatory concerns may restrain growth, strong innovation, AI integration, and expanding adoption in emergency and specialty clinics will sustain long-term expansion. North America remains dominant, while Asia Pacific is expected to emerge as the fastest-growing region during the forecast period.
Segmentation By Type
By End User
By Geography